Eric Coldwell
Stock Analyst at Baird
(5.00)
# 7
Out of 4,829 analysts
191
Total ratings
47.22%
Success rate
364.15%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Neutral | $118 → $140 | $143.08 | -2.15% | 14 | May 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $195 → $161 | $156.13 | +3.12% | 17 | May 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Neutral | $192 → $160 | $140.22 | +14.11% | 20 | May 2, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $156 → $170 | $148.62 | +14.39% | 12 | May 2, 2025 | |
| LH Labcorp Holdings | Maintains: Outperform | $253 → $267 | $250.94 | +6.40% | 13 | Apr 30, 2025 | |
| MEDP Medpace Holdings | Maintains: Neutral | $340 → $313 | $313.74 | -0.24% | 18 | Apr 23, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $191 → $194 | $175.90 | +10.29% | 10 | Apr 23, 2025 | |
| OMI Owens & Minor | Maintains: Neutral | $10 → $11 | $7.15 | +53.85% | 17 | Mar 3, 2025 | |
| AHCO AdaptHealth | Maintains: Outperform | $14 → $16 | $9.11 | +75.73% | 10 | Feb 27, 2025 | |
| PINC Premier | Maintains: Neutral | $20 → $19 | $23.01 | -17.43% | 7 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $28 → $25 | $5.19 | +381.70% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $531 → $688 | $687.52 | +0.07% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $51 | $11.40 | +347.37% | 16 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $45 | $57.03 | -21.09% | 2 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $66 | $64.81 | +1.84% | 7 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $46 | $1.52 | +2,926.32% | 4 | Nov 10, 2017 |
Charles River Laboratories International
May 8, 2025
Maintains: Neutral
Price Target: $118 → $140
Current: $143.08
Upside: -2.15%
IQVIA Holdings
May 7, 2025
Maintains: Neutral
Price Target: $195 → $161
Current: $156.13
Upside: +3.12%
ICON Public Limited Company
May 2, 2025
Maintains: Neutral
Price Target: $192 → $160
Current: $140.22
Upside: +14.11%
Cardinal Health
May 2, 2025
Maintains: Outperform
Price Target: $156 → $170
Current: $148.62
Upside: +14.39%
Labcorp Holdings
Apr 30, 2025
Maintains: Outperform
Price Target: $253 → $267
Current: $250.94
Upside: +6.40%
Medpace Holdings
Apr 23, 2025
Maintains: Neutral
Price Target: $340 → $313
Current: $313.74
Upside: -0.24%
Quest Diagnostics
Apr 23, 2025
Maintains: Outperform
Price Target: $191 → $194
Current: $175.90
Upside: +10.29%
Owens & Minor
Mar 3, 2025
Maintains: Neutral
Price Target: $10 → $11
Current: $7.15
Upside: +53.85%
AdaptHealth
Feb 27, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $9.11
Upside: +75.73%
Premier
Feb 5, 2025
Maintains: Neutral
Price Target: $20 → $19
Current: $23.01
Upside: -17.43%
Dec 6, 2024
Downgrades: Neutral
Price Target: $28 → $25
Current: $5.19
Upside: +381.70%
Nov 7, 2024
Upgrades: Outperform
Price Target: $531 → $688
Current: $687.52
Upside: +0.07%
Apr 1, 2022
Downgrades: Neutral
Price Target: $51
Current: $11.40
Upside: +347.37%
Jun 26, 2020
Maintains: Neutral
Price Target: $35 → $45
Current: $57.03
Upside: -21.09%
May 7, 2020
Maintains: Neutral
Price Target: $62 → $66
Current: $64.81
Upside: +1.84%
Nov 10, 2017
Maintains: Outperform
Price Target: $67 → $46
Current: $1.52
Upside: +2,926.32%